Use of GnRHa During Chemotherapy for Fertility Protection — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(17 sites)
Sweden
Center for Pediatric Cancer, Queen Silvia Hospital for Children and Youth, Gothenburg Center for Pediatric Oncology, Akademiska Hospital, Gothenburg Department of Oncology, Sahlgrenska University Hospital, Gothenburg Department of Hematology, Skåne University Hospital, Lund Department of Oncology, Skåne University Hospital, Lund Department of Pediatric Oncology, Skåne University Hospital, Lund Department of Oncology, Örebro University Hospital, Örebro Karolinska Univeristy Hospital, Breast Centre, Stockholm Department of Hematology and coagulation, Sahlgrenska University Hospital, Stockholm Department of Hematology, Capio ST. Göran Hospital, Stockholm Department of Internal Medicine, Södersjukhuset, Stockholm Department of Oncology, Capio ST. Göran Hospital, Stockholm Department of Oncology, Södersjukhuset, Stockholm Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm Karolinska University Hospital, Hematology, Stockholm Karolinska University Hospital, High Specialised Pediatric Medicine, Stockholm Department of Oncology, Norrlands University Hospital, Umeå Last updated October 2023